Estradiol Gel vs. Estradiol Spray: What the FDA Labels Actually Show

All four products, side by side

Assembled from each product's current FDA or DailyMed prescribing information. Checked July 10, 2026.

Does estradiol gel or spray have a black box warning?

Yes, and it depends which one. On February 12, 2026, the FDA approved labeling changes removing cardiovascular disease, breast cancer, and probable dementia from the boxed warning — but only for six products: Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva. Divigel is the only product on this page among them. Evamist, EstroGel, and Elestrin still carry their fuller boxed warnings.

A boxed warning — the “black box” — is the strongest warning the FDA puts on a prescription label.

The timeline, plainly:

• November 10, 2025: HHS and the FDA announce they will begin removing broad boxed warnings from menopausal hormone therapy products, citing a re-analysis of Women's Health Initiative data in younger women.
• February 12, 2026: The FDA approves the first batch of labeling changes. Six products. Divigel is one of them. The agency has said 29 companies submitted proposals.
• July 10, 2026: We checked the FDA's own published list. Evamist, EstroGel, and Elestrin are not on it.

The endometrial cancer boxed warning stays on systemic estrogen-alone products regardless. For Divigel, it is now the only topic left in the box. For the other three, it sits alongside the older, broader warnings.

Evamist carries a five-topic boxed warning that the other three don't: it specifically addresses unintended secondary exposure, including reports of breast development in children who had skin contact with a treated adult.

We re-check this monthly. If another product's label changes, this section changes and the date at the top of this page changes with it.

What does each label say about absorption?

Every number below comes from a different study, in a different group of women, over a different duration. Both labels state outright that comparing exposure across estrogen products may not validly predict effectiveness or safety. We show you what each company measured — not a ranking.

Evamist

Approved in a 12-week placebo-controlled trial of 454 postmenopausal women with moderate-to-severe hot flashes. One spray delivers 1.53 mg of estradiol to the inner forearm. Application to skin other than the inner forearm has not been adequately studied.

EstroGel

One pump delivers 0.75 mg of estradiol, applied to the whole arm from wrist to shoulder. In a label study, sunscreen applied one hour after the dose decreased measured 24-hour absorption by 16%. Moisturizer raised mean 24-hour exposure by 38% and peak concentration by 73%.

Divigel

Comes in five packet strengths, applied to the upper thigh in an area of about 5 by 7 inches, and the label instructs letting it dry completely without giving a specific minute count. Sunscreen interaction was not studied on this label.

Elestrin

One pump delivers 0.87 mg of estradiol, applied to the upper arm and shoulder over roughly 320 cm². In a label study, sunscreen applied 10 minutes before the dose increased measured exposure by about 55% — the opposite direction from EstroGel's sunscreen result.

Can estradiol gel or spray transfer to someone else?

Yes, all four products carry skin-transfer precautions, and Evamist's boxed warning is built specifically around it.Reports include breast development in prepubertal girls and boys after contact with a treated adult's skin; most cases resolved once exposure stopped.

If you're reading this because something scared you, take a breath first. The precautions exist precisely because this is manageable when you follow them.

The 2025 gel-transfer study is worth sitting with: contact within about an hour of application was where transfer showed up, and washing the contact site brought it back down. That's the same logic behind Evamist's stricter language — the spray's label simply spells it out as a boxed warning because its own trial data prompted that.

The practical version, for any of the four: apply, let it dry for the time your label states, keep it covered once dry if someone might touch that skin, and wash your hands after applying. If skin contact happens before it's dry, wash the other person's skin with soap and water.

If you've already had a contact exposure and you're worried, that's a conversation for your prescriber or pediatrician — not something to solve by switching products on your own.

What side effects does each label actually report?

We could not independently confirm common adverse-reaction percentages for Divigel, Elestrin, and Evamist in the sources we reviewed as of July 10, 2026. We're not going to fabricate a table to fill that gap. Here's what each label does state.

All four labels list estrogen's class-wide risks: breast tenderness, headache, nausea, bloating, and irregular bleeding are commonly described across transdermal estrogen products generally. Evamist's label separately documents application-site reactions tied to the spray delivery itself. Follow your own product's full label for the complete list — this page summarizes, it does not replace it.

Both EstroGel and Elestrin note that adverse reaction rates observed in one product's clinical trials cannot be directly compared to rates in another product's trials, because of differing trial conditions. That caution appears on multiple labels in this comparison, and we're repeating it because it's the single most misapplied fact in online estrogen comparisons.

How fast does each one work?

No label on this page states a guaranteed number of days or weeks to symptom relief. Each trial measured hot-flash frequency and severity at fixed check-in points — typically 4 and 12 weeks — against placebo, not a “time to relief” endpoint. If you're several weeks in without change, that's a reason to call your prescriber about dose or product, not to assume it's not working at all.

Which one for you: a label-based, not a marketing-based, table

These are not the cheapest forms of estradiol, and both gel and spray are daily. If price or a once- or twice-weekly routine matters more to you than these differences, the patch may be worth a look instead — see our estradiol patch vs estradiol gel comparison. But a patch brings its own adhesive and skin-irritation tradeoffs, and if you already ruled out a patch for that reason, gel and spray give you five labeled strengths across four products and no adhesive to manage.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

How much do these cost without insurance?

The brand name may not be costing you what you think. Generic estradiol gel exists for two of these four products. If price is driving your choice and you haven't asked your pharmacy about the generic option for your prescribed product, that's the first call to make — before comparing brands against each other.

Do I need a progestogen with any of these?

If you have a uterus, yes — systemic estrogen without a progestogen raises endometrial cancer risk, and all four products here are estrogen-alone.This warning was retained across the FDA's 2026 labeling changes, including for Divigel.

None of the four products compared on this page contains a progestogen. If you still have a uterus, your prescriber needs a separate plan for endometrial protection — typically an oral progestogen, though the exact regimen depends on your situation. After a hysterectomy you generally don't need one, though a history of endometriosis can change that conversation. Read more in our progesterone vs progestin comparison.

What should I ask before switching between these products?

Before you or your pharmacy change anything, bring these ten questions to the conversation:

1. What is the exact product and dose I'm being switched to?
2. Why is this switch happening — cost, stock, or a clinical reason?
3. Does the new product's application site or dry time differ from what I'm used to?
4. Do I need to change any of my other habits (sunscreen, moisturizer, timing)?
5. What symptoms should I watch for in the first few weeks?
6. What do I do with the leftover medication?
7. When will we review whether it's working?
8. Does my endometrial protection plan change?
9. What should make me call you sooner?
10. If the pharmacy substitutes a generic, will the instructions be identical?

Question 10 is the one people forget, and it's the one that bites. Generic estradiol gel 0.1% and generic estradiol gel 0.06% are different concentrations, in different containers, applied to different parts of the body. A substitution is not always a swap.

Does the evidence favor gel or spray?

Neither, in the head-to-head sense. In our July 2026 review of all four FDA labels and the published literature, we found no randomized trial comparing estradiol gel to estradiol spray directly, and neither label reports one. Each product was approved on its own placebo-controlled trial: Evamist in a 12-week study of 454 women; EstroGel and Divigel in their own separate trials. Comparing them means comparing across studies, which both labels explicitly caution against.

That's the honest answer, and it's more useful than a manufactured one.

What about blood clots?

You'll read everywhere that transdermal estrogen is safer for clots than pills. Here's what's actually established.

The Menopause Society's 2022 position statement says transdermal routes and lower doses of hormone therapy may decrease the risk of venous blood clots and stroke.

That “may” is carrying weight. The conclusion rests on observational studies, not randomized trials, and the society notes that comparative randomized data are lacking. The FDA labels on these products say the relevance of Women's Health Initiative findings to other routes of administration is not known.

Observational means researchers watched what happened to women who happened to choose different treatments. Randomized means treatment was assigned by chance — the only design that rules out healthier women choosing patches in the first place.

So: transdermal is a reasonable route, and many clinicians prefer it for women at higher clot risk. But nothing in that evidence distinguishes gel from spray. Both are transdermal.

Anyone telling you the spray is safer than the gel, or the gel safer than the spray, is telling you something no study has shown.

Where do you get FDA-approved estradiol gel or spray online?

Both require a prescription.An online provider stating that it “offers estradiol” does not prove it prescribes a specific brand, in your state, at a price you can see before you pay. Verify the exact product, the pharmacy, the state, the medication cost, and the follow-up policy before you commit.

We hold ourselves to a rule here, and it costs us money.

We do not publish a provider as offering a product until we can show the exact product name, FDA-approved versus compounded status, state availability, insurance or cash model, consultation price, medication price (or “confirmed at intake”), the dispensing pharmacy, the cancellation policy, and the date we checked.

We have not verified brand-level stocking for any provider on this page. So our links say “check whether they take your insurance,” not “get Evamist here.” If you see a site promising the second thing, ask them how they know.

Provider-stated vs. independently verified

Provider pages checked July 10, 2026.

Why Alloy is on this list. Alloy is not one of our partners and there's no link to it here. It's on this table because it publicly names Evamist — and a provider-stated-versus-verified framework that quietly omits the one provider naming the product isn't a framework. It's a funnel. We'd rather you know.

Why Winona isn't the pick here. This page compares four FDA-approved brand-name products. A compounded cream is a different category — custom-mixed by a pharmacy, not reviewed through the FDA approval process. We won't present it as an equivalent option on a page about FDA-approved products. If compounded therapy interests you, read about it on its own terms in our compounded vs. FDA-approved HRT guide.

What we actually verified

Product-label claims on this page were checked against current FDA or DailyMed records. Route-level medical context was checked against FDA, The Menopause Society, and the cited peer-reviewed literature. Price and provider claims were checked against the named commercial source on the date shown. Our fit conclusions are labeled separately as editorial. No clinician reviewed this page, and we say so rather than implying otherwise.

Read directly, July 10, 2026

• FDA's index of menopausal hormone therapies with updated prescribing information (content current as of 02/12/2026)
• Divigel prescribing information, revised 2/2026
• EstroGel prescribing information on DailyMed, revised 5/2026
• Elestrin prescribing information on DailyMed
• Evamist prescribing information on DailyMed
• FDA press announcements dated 11/10/2025 and 2/12/2026
• The Menopause Society's 2022 hormone therapy position statement
• Frontiers in Endocrinology, 2025, on estradiol gel skin transfer
• Published prices at GoodRx, SingleCare, and Drugs.com
• Published pages of Midi Health, Sesame Care, Alloy, Hers, and Winona

Could not independently confirm

• Whether every generic estradiol gel manufacturer has adopted the updated 2/2026 boxed warning
• Pharmacy-level availability of Elestrin, and its current pricing
• Common adverse-reaction percentages for Divigel, Elestrin, and Evamist
• Whether any telehealth provider currently prescribes a specific brand in your state
• Brand Divigel's true retail range — published sources differ by more than a factor of ten

We did not

Test these products. Receive samples. Accept payment from any manufacturer. Have this page reviewed by a clinician. Collect or publish patient testimonials.

On that last one. We looked for real, attributable patient quotes and didn't find any we could source and verify. We won't invent them. On a page comparing two prescription drugs, “the spray worked better for me” is a medical effectiveness claim, and one person's experience can't support one. Zero testimonials is a decision here, not an oversight.

How we review providers

The HRT Index Verification Standard is our documented process: we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, full roster quarterly.

We evaluate providers on exactly five pillars, always in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We do not assign numeric scores. A number would claim a precision we don't have.

Found something wrong? Tell us → We publish corrections with dates.

Frequently asked questions

Still not sure which HRT program is right for you?

Take our free matching quiz.

The HRT Index's Find My HRT Path tool matches your symptoms, your uterus status, your state, your insurance, and your route preference to the right provider — and flags when online care isn't the right starting point.

You came here confused about two forms of the same hormone. You're leaving with a shortlist, the label precautions that go with it, and the exact questions to ask.

Take it to someone who can prescribe it.

Sources

Labels read on DailyMed or FDA.gov, July 10, 2026. Prices and provider pages checked July 10, 2026.

1. FDA. Menopausal Hormone Therapies with Updated Prescribing Information. Content current as of 02/12/2026.
2. FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. February 12, 2026.
3. FDA. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies. November 10, 2025.
4. Divigel (estradiol gel 0.1%) prescribing information, rev. 2/2026.
5. EstroGel (estradiol gel 0.06%) prescribing information, DailyMed, rev. 5/2026.
6. Elestrin (estradiol gel 0.06%) prescribing information, DailyMed.
7. Evamist (estradiol transdermal spray) prescribing information, DailyMed.
8. Morton TL et al. Steady-State Pharmacokinetics Following Application of a Novel Transdermal Estradiol Spray in Healthy Postmenopausal Women. J Clin Pharmacol, 2009.
9. Schumacher RO et al. Effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray. PMID 18779758.
10. Avoiding touching until 60 min — contamination of transdermal estradiol gel after physical contact. Frontiers in Endocrinology, 2025. PMC12185294.
11. The North American Menopause Society. The 2022 Hormone Therapy Position Statement. Menopause. 2022;29(7).
12. MedlinePlus. Estradiol Topical. U.S. National Library of Medicine.
13. GoodRx, SingleCare, and Drugs.com published prices, retrieved July 10, 2026.
14. Published provider pages: Midi Health, Sesame Care, Alloy, Hers, Winona.